- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01067885
A Post-market Registry of the MARIS-stent (Invatec) Implanted in the Superficial Femoral Artery (MARIS)
MARIS - Prospective, Multicenter Registry
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recent data suggest that there is some evidence for a reduced restenosis rate for the implantation of a self expanding nitinol stent in the superficial femoral artery (SFA) compared to implantation of balloon expandable stents or single balloon inflation (ABSOLUTE study/FAST study).
The purpose of the Maris Register is to evaluate the primary nitinol stent implantation in an all comer population with diseased SFA.
The MARIS Register is a prospective, multicenter registry of the implantation of at least one at most five nitinol stents (Maris / Invatec) in the SFA without limitations for stenosis or occlusion length.
The registry includes 998 patients from 13 German investigational sites. Clinical data are captured on electronic case report forms
The primary endpoint is the target lesion revascularization after 12 month
Secondary endpoints are :
- Restenosis rate > 50% according to ultrasound criteria
- Restenosis rate > 70% according to ultrasound criteria
- Location of restenosis (proximal, middle, distal AFS)
- Number of stent fractures (grading according to FESTO criteria)
- Procedure related complication rate
- Vascular complication rate within 12 month
- Amputations within 12 month
- Deaths within 12 month
In order to measure the restenosis the peak systolic velocity (PSV) is to be measured in two sections during the duplex ultrasound examinations at 6 and 12 month. First measurement is performed 2cm proximal to the first stent, second measurement at the location where the maximum peak velocity over all lesions/all implanted stents is measured.
The clinical status includes the patient´s Fontaine classification.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- stent implantation in SFA is possible
- existing SFA stenosis 70-100 % (visual estimation)
- absence of homodynamically relevant stenosis in A. poplitea
- at least one lower limb run off vessel
Exclusion criteria
- pregnancy
- life expectancy less than 1 year
- coagulation disorder
- chronic anticoagulation therapy
- active gastrointestinal bleeding
- thrombolytic therapy within 72 hours before intervention
- hyperthyreosis
- severe contrast agent allergy
- allergy to concomittant medication
- severe liver disease
- thrombus in target lesion
- target lesion extend into A. poplitea
- severe calcification of target vessel, where no successful pre-dilatation is feasible
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
target lesion revascularization
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Restenosis rate > 50% according to ultrasound criteria
Time Frame: 6 and 12 month
|
6 and 12 month
|
Restenosis rate > 70% according to ultrasound criteria
Time Frame: 6 and 12 month
|
6 and 12 month
|
Location of restenosis (proximal, middle, distal AFS)
Time Frame: 6 and 12 month
|
6 and 12 month
|
Number of stent fractures (grading according to FESTO criteria)
Time Frame: 12 month
|
12 month
|
Procedure related complication rate
Time Frame: Discharge
|
Discharge
|
Vascular complication rate within 12 month
Time Frame: 12month
|
12month
|
Amputations within 12 month
Time Frame: 12month
|
12month
|
Deaths within 12 month
Time Frame: 12month
|
12month
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Hans Krankenbeg, MD, MCC Prof. Mathey, Prof. Schofer
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MARIS-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Artery Disease
-
Janssen Scientific Affairs, LLCHCA Research Institute, LLCRecruitingCoronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)United States
-
Michael Lichtenberg, MDCompletedPeripheral Artery Disease (PAD)Germany
-
Helsinki University Central HospitalCompletedPeripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery RestenosisFinland
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedStructural Heart Disease | Obstructive Coronary Artery Disease | Obstructive Peripheral Artery DiseaseUnited States
-
Fangge DengRecruitingPeripheral Artery Disease (PAD)China
-
Fundacion para la Formacion e Investigacion Sanitarias...Not yet recruiting
-
Rontis Hellas SAPharmassist LtdActive, not recruitingPeripheral Artery Disease (PAD)Greece
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
Seung-Whan Lee, M.D., Ph.D.Active, not recruitingCatheterization, Peripheral | Popliteal Artery | Angioplasty, Balloon | Femoral ArteryKorea, Republic of
-
Dartmouth-Hitchcock Medical CenterSociety for Vascular SurgeryCompletedPeripheral Artery Disease (PAD)United States
Clinical Trials on MARIS-stent (Invatec)
-
Deutsches Herzzentrum MuenchenUnknownPeripheral Vascular DiseasesGermany
-
Xuanwu Hospital, BeijingUnknownDiabetes | Popliteal Artery Occlusion | Popliteal StenosisChina
-
Institute of Cardiology, Warsaw, PolandCompleted
-
Medical Care Center Prof. Mathey, Prof. Schofer...CompletedPeripheral Vascular DiseaseGermany
-
Deutsches Herzzentrum MuenchenUnknownPeripheral Vascular DiseaseGermany
-
Centro Cardiologico MonzinoCompletedCarotid StenosisItaly
-
Zhujiang HospitalNanfang Hospital of Southern Medical University; Guangdong Provincial People...UnknownTrials of Clinical Curative Effect, Follow-up Study and Hemodynamics of Treatment of IA Using StentsTreatment Outcome by Stent-assisted EmbolizationChina
-
Xuanwu Hospital, BeijingWithdrawnStroke | Carotid StenosisChina
-
Royal Sussex County HospitalTerumo CorporationCompletedCoronary DiseaseUnited Kingdom
-
Southeast University, ChinaUnknownEsophageal CancerChina